Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Takaki Kikuchi"'
Autor:
Tomotaka Suzuki, Rui Yokomori, Takaomi Sanda, Takaki Kikuchi, Yoshiaki Marumo, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
We report a 69-year-old female who was a human T-cell leukemia virus type 1 carrier and exhibited a unique clinical course of developing three hematological malignancies within a short period: diffuse large B-cell lymphoma (DLBCL), chronic myelomonoc
Externí odkaz:
https://doaj.org/article/8aba716dd1a04644967bae0b971ebc08
Autor:
Takafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, Junki Yamamoto, Satoshi Osaga, Haruna Fujinami, Takaki Kikuchi, Tomotaka Suzuki, Haruhito Totani, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Kazuaki Wakami, Toshihiko Goto, Tomonori Sugiura, Yoshihiro Seo, Nobuyuki Ohte, Shinsuke Iida
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 498-506 (2020)
Abstract We investigated the incidence of cardiotoxicity, its risk factors, and the clinical course of cardiac function in patients with malignant lymphoma (ML) who received a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regime
Externí odkaz:
https://doaj.org/article/87ae7445493b4183952f1ca81d57c702
Autor:
Yoshiaki Marumo, Hiroshi Inagaki, Shinsuke Iida, Hirokazu Komatsu, Takaki Kikuchi, Fumiko Mori, Shigeru Kusumoto, Atsushi Inagaki, Ayako Masaki, Takahiro Nakashima
Publikováno v:
International Journal of Hematology. 114:280-285
Malignant lymphoma developing during anti-PD-1 antibody treatment is extremely rare. A 74-year-old female was admitted with left hypochondrial pain. She was diagnosed with squamous cell carcinoma of the right upper lobe of the lung, and had undergone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e338aa91f95866355d97a6fb5b2f3b0
https://doi.org/10.1007/s12185-021-03135-5
https://doi.org/10.1007/s12185-021-03135-5
Autor:
Yoshiko Oshima, Yoshihiro Seo, Haruna Fujinami, Satoshi Osaga, Tomotaka Suzuki, Tomonori Sugiura, Shigeru Kusumoto, Haruhito Totani, Nobuyuki Ohte, Tomoko Narita, Kazuaki Wakami, Hirokazu Komatsu, Toshihiko Goto, Takaki Kikuchi, Shiori Kinoshita, Asahi Ito, Junki Yamamoto, Takafumi Nakayama, Masaki Ri, Shinsuke Iida
Publikováno v:
eJHaem. 1:498-506
We investigated the incidence of cardiotoxicity, its risk factors, and the clinical course of cardiac function in patients with malignant lymphoma (ML) who received a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regimen. Among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023b4be114ea3104982bd44daec1cd2b
https://doi.org/10.1002/jha2.110
https://doi.org/10.1002/jha2.110
Autor:
Yasuhito Tanaka, Yu Asao, Shigeru Kusumoto, Tomoko Narita, Shiori Kinoshita, Masaki Ri, Yoshiko Oshima, Haruna Fujinami, Shinsuke Iida, Haruhito Totani, Asahi Ito, Tomotaka Suzuki, Hirokazu Komatsu, Takaki Kikuchi
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
A 72-year-old female complaining of back pain was diagnosed with IgG-κ multiple myeloma. After osteosynthesis for fracture of the left femoral shaft due to myeloma, she received bortezomib, melphalan, and prednisolone as an initial regimen for multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e18ac5eb7f3cac50b8a2b0771f73f293
http://europepmc.org/articles/PMC7337267
http://europepmc.org/articles/PMC7337267
Autor:
Tomotaka Suzuki, Rui Yokomori, Takaomi Sanda, Takaki Kikuchi, Yoshiaki Marumo, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Publikováno v:
Frontiers in Oncology; 2/17/2023, Vol. 13, p1-6, 6p
Autor:
Ayako Masaki, Shinsuke Iida, Fumiko Mori, Atsushi Inagaki, Hiroshi Inagaki, Shigeru Kusumoto, Hirokazu Komatsu, Takaki Kikuchi, Yoshiaki Marumo, Shiori Kinoshita
Publikováno v:
Annals of Oncology. 30:vi121-vi122
Introduction There is limited evidence regarding the impact of updated Charlson comorbidity index (CCI) on survival in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) receiving rituximab, cyclophosphamide, doxorubicin, vincristine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c640bf78acdd7acea8d64e8120269f0f
https://doi.org/10.1093/annonc/mdz343.017
https://doi.org/10.1093/annonc/mdz343.017
Publikováno v:
Kyushu Plant Protection Research. 59:57-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28e1703c78444f62f707b1cb6ac1b529
https://doi.org/10.4241/kyubyochu.59.57
https://doi.org/10.4241/kyubyochu.59.57
Autor:
Keisuke Kijima, Masayuki Shimatani, Akiko Miyagi, Hirosato Kodama, Ayako Yamaguchi, Suguru Ohno, Miki Kurima, Tomoko Ganaha-Kikumura, Mika Takaki-Kikuchi
Publikováno v:
Japanese Journal of Applied Entomology and Zoology. 56:74-77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ef1633bd095aabc11d156c761fb71ae
https://doi.org/10.1303/jjaez.2012.74
https://doi.org/10.1303/jjaez.2012.74
Autor:
Takayuki Kanamori, Kenji Ina, Sayaka Sugiura, Megumi Kabeya, Satoshi Kayukawa, Ryuichi Furuta, Shu Yuasa, Satoshi Hibi, Takaki Kikuchi, Takae Kataoka
Publikováno v:
Journal of Analytical Oncology. 4
Objective : Bevacizumab has been increasingly used in combination chemotherapy for the treatment of metastatic or recurrent colorectal cancer. The aim of this report is to underline the possible risks associated with bevacizumab use. Methods : Betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c983f412539d6b38c78ab34a17c9c41
https://doi.org/10.6000/1927-7229.2015.04.01.4
https://doi.org/10.6000/1927-7229.2015.04.01.4